RxDoctor Payments Data

Nicholas Thornton, MD

Family Medicine · Powell, TNNPI 1831130731

Payments from drug & device makers

$7,045in general payments, 2019–2025

Across 442 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Pfizer$619
  • AbbVie$607
  • AstraZeneca$566
  • Boehringer Ingelheim$469
  • GSK$452
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$7,038100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,045 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$93,969
Medicare patients
169
Services billed
6,204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$51,612
Tresiba Flextouch U-200Insulin Degludec26$49,447
GlyxambiEmpagliflozin/Linagliptin30$34,473
OzempicSemaglutide16$32,257
Trijardy XrEmpaglifloz/Linaglip/Metformin22$28,135
TrulicityDulaglutide13$26,725
Janumet XrSitagliptin Phos/Metformin Hcl20$25,891
MounjaroTirzepatide21$21,900
XareltoRivaroxaban17$15,640
Synjardy XrEmpagliflozin/Metformin Hcl18$15,189
BrilintaTicagrelor13$6,165
FarxigaDapagliflozin Propanediol13$4,176
Wixela InhubFluticasone Propion/Salmeterol19$3,185
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,679
Levothyroxine Sodium265$2,249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimGlyxambi, Trijardy Xr, Synjardy Xr$469$77,79770 claims
PfizerEliquis$619$51,61240 claims
Lilly USA, LLCTrulicity, Mounjaro$292$48,62434 claims
Novo NordiskOzempic$1,332$32,25716 claims
MerckJanumet Xr$140$25,89120 claims
Johnson & JohnsonXarelto$181$15,64017 claims
AstraZenecaBrilinta, Farxiga$566$10,34126 claims
GSKShingrix$452$2,67912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Powell

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →